Skip to main content

Advertisement

SpringerLink
Log in

Deciphering Intellectual Disability

  • Review Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Intellectual disability (ID) is a common cause of referral to the pediatricians, geneticists, and pediatric neurologists. A thorough clinical evaluation and a stepwise investigative approach using a combination of traditional genetic techniques and appropriate latest genomic technologies can help in arriving at a diagnosis. In the current “omics” era, adopting a multiomics approach would further assist in solving the undiagnosed cases with intellectual disability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Association of Intellectual and Developmental Dis- abilities (AAIDD). Defining Criteria for Intellectual Disability. Available at: http://aaidd.org/intellectual-disability/definition. Accessed on 30 Aug 2022.

  2. American Psychiatric Association. Intellectual Disability (Intellectual Developmental Disorder). In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington: American Psychiatric Association. 2013.

  3. Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet. 1997;72:468–77.

    Article  Google Scholar 

  4. Juneja M, Gupta A, Sairam S, et al. Diagnosis and management of global development delay: consensus guidelines of growth, development and behavioral pediatrics chapter, neurology chapter and neurodevelopment pediatrics chapter of the Indian Academy of Pediatrics. Indian Pediatr. 2022;59:401–15.

  5. Marti, et al. Intellectual disability, the long way from genes to biological mechanisms. J Transl Genet Genom. 2020;4:104–13.

    Google Scholar 

  6. Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–7.

    Article  CAS  Google Scholar 

  7. Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542:433–8.

    Article  Google Scholar 

  8. Martin HC, Jones WD, McIntyre R, et al. Deciphering Developmental Disorders Study. Quantifying the contribution of recessive coding variation to developmental disorders. Science. 2018;362:1161–4.

    Article  CAS  Google Scholar 

  9. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, et al. Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app. Orphanet J Rare Dis. 2021;16:170.

    Article  Google Scholar 

  10. Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77:1629–35.

    Article  CAS  Google Scholar 

  11. Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H. Array CGH in patients with learning disability (mentalretardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med. 2009;11:139–46.

    Article  CAS  Google Scholar 

  12. Vissers LE, de Ligt J, Gilissen C, et al. A de novo paradigm for mental retardation. Nat Genet. 2010;42:1109–12.

    Article  CAS  Google Scholar 

  13. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64.

    Article  CAS  Google Scholar 

  14. Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015;519:223–8.

    Article  Google Scholar 

  15. de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367:1921–9.

    Article  Google Scholar 

  16. Bruel AL, Vitobello A, Tran Mau-Them F, et al. Next-generation sequencing approaches and challenges in the diagnosis of developmental anomalies and intellectual disability. Clin Genet. 2020;98:433–44.

    Article  CAS  Google Scholar 

  17. Lindstrand A, Eisfeldt J, Pettersson M, et al. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability. Genome. 2019;11:68.

    Article  Google Scholar 

  18. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312:1880–7.

    Article  Google Scholar 

  19. Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42:790–3.

    Article  CAS  Google Scholar 

  20. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502–11.

    Article  CAS  Google Scholar 

  21. Monies D, Abouelhoda M, AlSayed M, et al. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet. 2017;136:921–39.

    Article  CAS  Google Scholar 

  22. Iglesias A, Anyane-Yeboa K, Wynn J, et al. The usefulness of whole- exome sequencing in routine clinical practice. Genet Med. 2014;16:922–31.

    Article  Google Scholar 

  23. Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K, et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet. 2017;25:176–82.

    Article  CAS  Google Scholar 

  24. Lelieveld SH, Reijnders MR, Pfundt R, et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci. 2016;19:1194–6.

    Article  CAS  Google Scholar 

  25. Zahir FR, Mwenifumbo JC, Chun HE, et al. Comprehensive whole genome sequence analyses yields novel genetic and structural insights for intellectual disability. BMC Genomics. 2017;18:403.

    Article  Google Scholar 

  26. Manickam K, McClain MR, Demmer LA, et al; ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:2029–37.

    Article  Google Scholar 

  27. Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

    Article  Google Scholar 

  28. Köhler S, Vasilevsky NA, Engelstad M, et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017;45:D865–76.

    Article  Google Scholar 

  29. Gurovich Y, Hanani Y, Bar O, et al Kamphausen SB, Zenker M, Bird LM, Gripp KW. Identifying facial phenotypes of genetic disorders using deep learning. Nat Med. 2019;25:60–4.

    Article  CAS  Google Scholar 

  30. Hsieh TC, Mensah MA, Pantel JT, et al. PEDIA: prioritization of exome data by image analysis. Genet Med. 2019;21:2807–14.

    Article  Google Scholar 

  31. Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–30.

    Article  Google Scholar 

  32. Sobreira NLM, Arachchi H, Buske OJ, et al; Matchmaker Exchange Consortium. Matchmaker exchange. Curr Protoc Hum Genet. 2017;95:9.31.1–9.31.15.

  33. de Macena Sobreira NL, Hamosh A. Next-generation sequencing and the evolution of data sharing. Am J Med Genet A. 2021;185:2633–5.

    Article  Google Scholar 

  34. Buske OJ, Girdea M, Dumitriu S, et al. PhenomeCentral: a portal for phenotypic and genotypic matchmaking of patients with rare genetic diseases. Hum Mutat. 2015;36:931–40.

    Article  Google Scholar 

  35. Zhai Y, Zhang Z, Shi P, Martin DM, Kong X. Incorporation of exome-based CNV analysis makes trio-WES a more powerful tool for clinical diagnosis in neurodevelopmental disorders: a retrospective study. Hum Mutat. 2021;42:990–1004.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Genetics, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, Old OT Block, New Delhi, 110029, India

    Neerja Gupta

Authors
  1. Neerja Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neerja Gupta.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, N. Deciphering Intellectual Disability. Indian J Pediatr 90, 160–167 (2023). https://doi.org/10.1007/s12098-022-04345-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-022-04345-3

Keywords

Search

Navigation